Advertisement

Topics

Companies Related to "Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia" [Most Relevant Company Matches] RSS

02:19 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia" found in our extensive corporate database of over 50,000 company records.

Showing "Bortezomib Dexamethasone Rituximab Previously Untreated Patients With Waldenstrom" Companies 1–25 of 3,900+

Relevant

Celltrion Inc.

Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacture of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EMA approval for Inflectr...


DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and i...

Biogen Idec

Scientific excellence that achieves new standards of care drives the company's work. 17 products are currently in clinical development addressing a variety of key medical needs.With patients in more than 90 countries, two blockbuster drugs lead Biogen Idec's product lineup:RITUXAN® (rituximab) was discovered by Biogen Idec for the treatment of certain B-cell non-Hodgkin's lymphomas (NHL). The com...


ResMed, Inc.

ResMed is a leading developer, manufacturer and distributor of medical equipment for the treatment and management of sleep-disordered breathing and other respiratory disorders. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious h...

Guided Delivery Systems, Inc.

Guided Delivery Systems, Inc. is a privately funded, development-stage company founded in December 2002, based in Santa Clara, California. The company's mission is to become the industry leader in providing safe, minimally invasive and clinically effective solutions to millions of untreated patients with life impairing and potentially life threatening heart valve conditions. For more information...

Otonomy, Inc.

Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The company's core technology is a sustained release formulation developed for optimal delivery of drugs from a single intratympanic (IT) injection. Broad applicability of this delivery and formulation technology has already been established across a number of therapeuti...

Journal of Maternal-Fetal & Neonatal Medicine

"Left untreated, preeclampsia leads to serious - or fatal - complications for both the mother and baby," says Dr Kusanovic of the Perinatology Research Branch of the NIH and Wayne State University/Hutzel Women's Hospital in Detroit, Michigan and lead author of the study.

Nuna Inc.

Nuna Inc. was founded in 2010 by Jini Kim, previously a product manager with Google Health and a key member of the team that saved the roll-out of Healthcare.gov, and David Chen, previously a Senior Data Scientist at Netflix and a graduate of the biomedical informatics training program at Stanford. The company has raised over $90M in funding from Kleiner P...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular ...

Respiratory Motion, Inc.

ExSpiron continuously and noninvasively measures and displays lung volume against time, generating quantitative metrics for minute ventilation (the amount of air that enters/leaves the lungs every minute), respiratory rate (breaths per minute), and tidal volume (the volume of air in a single breath). Minute ventilation was previously only captured continuo...

TikoMed

Swedish-based TikoMed is an innovation driven biotechnology company focused on the development and commercialization of novel treatments for transplantation therapies and immune diseases. The board includes Anders Milton, former chairman of Swedish Red-Cross and Q-Med, Jan Sandström, previously Vice President Business Development at AstraZeneca and Gillis ...

Probably Relevant

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc. is a specialty pharmaceutical company whose mission is to greatly extend the lives of patients with solid tumor cancers. Intensity Therapeutics is pioneering a new approach to treat cancer referred to as in situ chemovaccination. The Company creates novel, proprietary formulations of proven chemotherapy drugs. These products, w...

Abreos Biosciences

Abreos Biosciences is focused on ligand binding assays for biologic and biosimilar drug development, activity validation, authentication, and precision dosing, as well as massively multiplexed biomarker assays. Abreos has already developed reagents for the detection of several drugs currently available on the market such as rituximab, obinutuzumab, trastuz...

Genzyme

Genzyme is one of the world’s leading biotechnology companies. Its more than 9,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases. Since its founding in 1981, Genzyme has grown from a small start-up to a diversified enterprise with 2006 revenues of $3.2 billion. Over the past two...

Life Time Pharmaceuticals Incorporated

LifeTime™ Pharmaceuticals, a private clinical-stage pharmaceutical company, focuses on the development of drugs that are safe enough for long-term, chronic administration. Compounds currently under development seek to eliminate and prevent recurrence of potentially fatal cancers and infectious syndromes. Human clinical trial results presented at several scientific meetings (see below) have shown...

Bone Care International Incorporated

Bone Care is a leader in the discovery and development of improved vitamin D-hormone therapies for the treatment of secondary hyperparathyroidism and certain hyperproliferative diseases. D-hormones have a key role in the progression and management of secondary hyperparathyroidism in patient populations with kidney dysfunction, including kidney Dialysis, pre-dialysis, and certain osteoporosis pati...

The German Breast Group and Celgene Corporation

GBG is a large independent academic network of over 500 study centers in Germany with the world- wide largest experience in conducting neoadjuvant breast cancer trials. Since 1998, with joined forces from AGO-B, over 10.000 patients participated in the neoadjuvant “Gepardo” trial series. GBG has recruited at totality of over 35.000 patients to tr...

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. The value of these therapeutic assets is then significantly enhanced by global development programs prior to selling them as clinically and commercially validated products to established pharmaceutica...

US Oncology Network

Optim Oncology is dedicated to providing patient-centered, integrated cancer care in convenient locations close to patients’ homes. Medical and radiation specialists work together in one location to facilitate fully coordinated comprehensive team care, providing the potential for better outcomes and reducing patients’ stress by eliminating the need to ...

Cortical Pty Ltd

Inflammatory diseases can be successfully targeted with anti-cytokine therapies. Small molecule cytokine antagonists have never previously been developed, but may provide a valuable combination of effectiveness in treatment, potential oral administration, and a cost which may allow more patients to receive the treatment. In addition such molecules have the potential for formulation for use as a to...

Antidote Technologies Ltd

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of participants, Antidote use cutting-edge technology to match the right patients with the right trials. Antido...

Millennium Pharmaceuticals

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE® (bortezomib) for Injection, a novel cancer therapeutic, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology, and inflammation. By applying its knowledg...

BIOCAD

Based in St. Petersburg, Russia, joint-stock company BIOCAD is a leading Russian private biopharmaceutical company, specializing in the research, development and manufacture of generic, biosimilar, and innovative drugs. BIOCAD works to provide more affordable therapeutic proteins and small-molecule generics to patients who previously had limited access to ...

Evalve, Inc.

Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair.An estimated 4 mil...

BioDelivery Sciences International

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics. Our development strategy focuses on the utilization of the FDA’s 505(b)(2) approval process to obtain more timely and eff...


More From BioPortfolio on "Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks